MiniMed Group, Inc.(MMEDV)

Medical - Instruments & Supplies · Northridge, CA

$20.000.00 (0.00%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T14:57:51.896Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:57:51.896Z.

Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA: N/A
Quote market capitalization: 560,000,000
Total debt: N/A
Cash: N/A

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

MMEDV EBITDA Yield Metrics

EBITDA YIELD

N/A

MMEDV Competitors' EBITDA Yield

MMEDV

MiniMed Group, Inc.

Current

Market Cap

$560.00M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CTMX

CytomX Therapeutics, Inc.

vs MMEDV

Market Cap

$561.46M

EBITDA Yield

N/A

TTM Avg

31.68%

3Y Avg

26.65%

5Y Avg

26.65%

BLSM

BlossomHill Therapeutics, Inc.

vs MMEDV

Market Cap

$562.43M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRMD

CorMedix Inc.

vs MMEDV

Market Cap

$564.07M

EBITDA Yield

55.71%

TTM Avg

22.76%

3Y Avg

17.21%

5Y Avg

17.21%

ACRS

Aclaris Therapeutics, Inc.

vs MMEDV

Market Cap

$559.21M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AQST

Aquestive Therapeutics, Inc.

vs MMEDV

Market Cap

$568.99M

EBITDA Yield

N/A

TTM Avg

2.38%

3Y Avg

2.38%

5Y Avg

2.38%

NVCT

Nuvectis Pharma, Inc.

vs MMEDV

Market Cap

$545.59M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KIDS

OrthoPediatrics Corp.

vs MMEDV

Market Cap

$582.66M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCTH

Delcath Systems, Inc.

vs MMEDV

Market Cap

$537.16M

EBITDA Yield

N/A

TTM Avg

1.23%

3Y Avg

1.23%

5Y Avg

1.23%

IMMX

Immix Biopharma, Inc.

vs MMEDV

Market Cap

$534.50M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
MiniMed Group, Inc. (MMEDV)	$560.00M	N/A	N/A	N/A	N/A
CytomX Therapeutics, Inc. (CTMX)vs ›	$561.46M	N/A	31.68%	26.65%	26.65%
BlossomHill Therapeutics, Inc. (BLSM)vs ›	$562.43M	N/A	N/A	N/A	N/A
CorMedix Inc. (CRMD)vs ›	$564.07M	55.71%	22.76%	17.21%	17.21%
Aclaris Therapeutics, Inc. (ACRS)vs ›	$559.21M	N/A	N/A	N/A	N/A
Aquestive Therapeutics, Inc. (AQST)vs ›	$568.99M	N/A	2.38%	2.38%	2.38%
Nuvectis Pharma, Inc. (NVCT)vs ›	$545.59M	N/A	N/A	N/A	N/A
OrthoPediatrics Corp. (KIDS)vs ›	$582.66M	N/A	N/A	N/A	N/A
Delcath Systems, Inc. (DCTH)vs ›	$537.16M	N/A	1.23%	1.23%	1.23%
Immix Biopharma, Inc. (IMMX)vs ›	$534.50M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

MMEDV EBITDA Yield Metrics

MMEDV Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics